- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 81.92M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 81.92M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 81.84M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $114 |
| Capex | Q1 2026 · Mar 31, 2025 | $16.26K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$43.18K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$45.15K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.69M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.75M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.87M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.61M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.41M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.19M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.54M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.45M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.82M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.75M |
| Total Assets | Q1 2026 · Mar 31, 2025 | $3.91M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $509.62K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $485.83K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$152.57K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$482.43K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$165.16K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$489.46K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $340.77K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$6.91K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $934.76K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $628.09K |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.28M |
| Revenue | Q1 2026 · Mar 31, 2025 | $621.18K |